Skip to main content

Alvotech

ALVO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001898416

No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $157.4M in total; Oaktree Capital is the only superinvestor holding it.

Other share classesALVOW

Q4 2024 vs. Q3 2024

How the institutions holding Alvotech changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ALVO: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders3245+13
Shares15.2M15.4M+218.5K (+1.4%)
Value$178.2M$199.6M+$21.4M (+12.0%)

New holders (18)

Institutions that held Alvotech at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ALVO in Q4 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.839,234$11.1M0.00%
China Universal Asset Management Co., Ltd.56,576$748.5K0.07%
Goldman Sachs Group Inc25,871$342.3K0.00%
Tempus Wealth Planning, LLC23,467$310.5K0.09%
ADAR1 Capital Management, LLC20,600$272.5K0.06%
Vident Advisory, LLC20,272$268.2K0.00%
Barclays PLC15,860$209.8K0.00%
ProShare Advisors LLC12,639$167.2K0.00%
Invesco Ltd.11,210$148.3K0.00%
Mirae Asset Global Investments Co., Ltd.8,891$112.6K0.00%
GF Fund Management Co. Ltd.5,603$74.1K0.00%
BNP Paribas Arbitrage, SA4,961$65.6K0.00%
EverSource Wealth Advisors, LLC1,390$18.4K0.00%
Tower Research Capital LLC (TRC)961$12.7K0.00%
Daiwa Securities Group Inc.881$12.0K0.00%
Ronald Blue Trust, Inc.811$10.7K0.00%
Wells Fargo & Company400$5.29K0.00%
Royal Bank of Canada120$2.00K0.00%

Sold out (5)

Institutions that held Alvotech at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of ALVO in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
ExodusPoint Capital Management, LP34,111$406.0K
Marshall Wace, LLP33,213$395.2K
Citadel Advisors LLC21,249$252.9K
Cubist Systematic Strategies, LLC11,273$134.1K
FreeGulliver LLC43,681$118.4K